These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 2213756

  • 1. Immunoadsorbent plasma perfusion in patients with systemic lupus erythematosus.
    Schneider M, Berning T, Waldendorf M, Glaser J, Gerlach U.
    J Rheumatol; 1990 Jul; 17(7):900-7. PubMed ID: 2213756
    [Abstract] [Full Text] [Related]

  • 2. Immunoadsorbent (IM-P) plasma perfusion in patients with rheumatoid arthritis or SLE.
    Yamazaki Z, Iizuka I, Kanai F, Wada T, Fujimori Y, Takahama T, Asano K, Yoshizawa H, Takahashi T, Ogita T.
    Life Support Syst; 1983 Jul; 1 Suppl 1():98-101. PubMed ID: 6400736
    [No Abstract] [Full Text] [Related]

  • 3. Prospective randomized trial of two different immunoadsorbers in severe systemic lupus erythematosus.
    Gaubitz M, Seidel M, Kummer S, Schotte H, Perniok A, Domschke W, Schneider M.
    J Autoimmun; 1998 Oct; 11(5):495-501. PubMed ID: 9802935
    [Abstract] [Full Text] [Related]

  • 4. Antibodies against the VRT101 laminin epitope correlate with human SLE disease activity and can be removed by extracorporeal immunoadsorption.
    Amital H, Heilweil-Harel M, Ulmansky R, Harlev M, Toubi E, Hershko A, Naparstek Y.
    Rheumatology (Oxford); 2007 Sep; 46(9):1433-7. PubMed ID: 17686790
    [Abstract] [Full Text] [Related]

  • 5. Development of an in vitro miniature model to simulate immunoadsorption in patients with systemic lupus erythematosus.
    Avenhaus B, Avenhaus W, Schneider M, Domschke W, Gaubitz M.
    J Clin Apher; 2002 Sep; 17(4):183-9. PubMed ID: 12494411
    [Abstract] [Full Text] [Related]

  • 6. A new device for specific extracorporeal immunoadsorption of anti-DNA antibodies. In vitro and in vivo results.
    Traeger J, Laville M, Serres PF, Cronenberger M, Thomas M, Rey MJ, Bourgeat C.
    Ann Med Interne (Paris); 1992 Sep; 143 Suppl 1():9-12. PubMed ID: 1300896
    [Abstract] [Full Text] [Related]

  • 7. Study of plasma levels of soluble CD40 ligand in systemic lupus erythematosus patients who have undergone plasmapheresis.
    Kimura K, Tsuda H, Kwangseok Y, Tamura N, Kanai Y, Kobayashi S.
    Ther Apher Dial; 2005 Feb; 9(1):64-8. PubMed ID: 15828909
    [Abstract] [Full Text] [Related]

  • 8. Specific adsorption of circulating antibodies by extracorporeal plasma perfusions over antigen coated collagen flat-membranes: applications to systemic lupus erythematosus.
    El-Habib R, Laville M, Traeger J.
    J Clin Lab Immunol; 1984 Nov; 15(3):111-7. PubMed ID: 6397594
    [Abstract] [Full Text] [Related]

  • 9. [Use of plasmapheresis in therapy of systemic lupus erythematosus: a controlled study].
    Zielinski C, Müller C, Smolen J.
    Acta Med Austriaca; 1988 Nov; 15(5):155-8. PubMed ID: 3064527
    [Abstract] [Full Text] [Related]

  • 10. The development of a C1q anti-C1q immunoadsorbent for removal of immune complexes from plasma.
    Bratt T, Ohlson S.
    J Clin Lab Immunol; 1988 Dec; 27(4):191-5. PubMed ID: 3266946
    [Abstract] [Full Text] [Related]

  • 11. Monthly plasmapheresis for systemic lupus erythematosus with diffuse proliferative glomerulonephritis: a pilot study.
    Clark WF, Lindsay RM, Cattran DC, Chodirker WB, Barnes CC, Linton AL.
    Can Med Assoc J; 1981 Jul 15; 125(2):171-4. PubMed ID: 7272867
    [Abstract] [Full Text] [Related]

  • 12. Plasma exchange (plasmapheresis).
    Hughes GR.
    Agents Actions Suppl; 1980 Jul 15; 7():62-5. PubMed ID: 6941688
    [Abstract] [Full Text] [Related]

  • 13. [Value of plasma exchange in neurologic complications of acute disseminated lupus erythematosus in children].
    Couillault G, Gouyon JB, Chalopin JM, Rifle G, Nivelon JL.
    Arch Fr Pediatr; 1985 Jan 15; 42(1):41-3. PubMed ID: 3872647
    [Abstract] [Full Text] [Related]

  • 14. Plasmapheresis in the treatment of systemic lupus erythematosus.
    Błaszczyk M, Chorzelski T, Daszyński J, Gaczkowski A, Jabłońska S, Beutner EH.
    Arch Immunol Ther Exp (Warsz); 1981 Jan 15; 29(6):769-72. PubMed ID: 6983871
    [Abstract] [Full Text] [Related]

  • 15. Clinical trials of immunoadsorbent in systemic lupus erythematosus therapy.
    Gao CL, Li BA, Chen CZ, Yu YT, Yuan P, Song JC.
    Artif Organs; 1995 May 15; 19(5):468-9. PubMed ID: 7625928
    [Abstract] [Full Text] [Related]

  • 16. Anti-dsDNA antibody kinetics during in vivo apheresis in systemic lupus erythematosus patients and in an in vitro apheresis model.
    Suzuki K, Taman J, Matsuki Y, Hidaka T, Ishizuka T, Kawakami M, Yabuki T, Kutsuki H, Nakamura H.
    J Clin Apher; 1996 May 15; 11(4):211-6. PubMed ID: 8986867
    [Abstract] [Full Text] [Related]

  • 17. [Immunoadsorption therapy for myasthenia gravis: study on the adsorption capacity of an immunoadsorption column].
    Yeh JH, Chiu HC.
    J Microbiol Immunol Infect; 1999 Jun 15; 32(2):121-5. PubMed ID: 11565565
    [Abstract] [Full Text] [Related]

  • 18. Efficacy of plasma exchange and immunoadsorption in systemic lupus erythematosus and antiphospholipid syndrome: A systematic review.
    Kronbichler A, Brezina B, Quintana LF, Jayne DR.
    Autoimmun Rev; 2016 Jan 15; 15(1):38-49. PubMed ID: 26318215
    [Abstract] [Full Text] [Related]

  • 19. [Status of plasmapheresis and cyclosporin A in the treatment of systemic lupus erythematosus].
    Graf N, Bambauer R, Jost W, Schäfer M.
    Monatsschr Kinderheilkd; 1990 Jul 15; 138(7):395-8. PubMed ID: 2398909
    [Abstract] [Full Text] [Related]

  • 20. The severity of systemic lupus erythematosus negatively correlates with the increasing number of CD4+CD25(high)FoxP3+ regulatory T cells during repeated plasmapheresis treatments of patients.
    Baráth S, Soltész P, Kiss E, Aleksza M, Zeher M, Szegedi G, Sipka S.
    Autoimmunity; 2007 Nov 15; 40(7):521-8. PubMed ID: 17966042
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.